#antibody — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #antibody, aggregated by home.social.
-
https://www.europesays.com/ie/713377/ New mathematical model tracks how tumor environment impacts cancer therapies #Antibody #AntibodyDrugConjugate #blood #cancer #CancerTherapy #Efficacy #Éire #IE #Immunomodulatory #immunotherapy #Ireland #oncology #Research #Technology #therapy #Tumor #Vascular
-
New mathematical model tracks how tumor environment impacts cancer therapies
Researchers from Mass General Brigham and the University of Cyprus have developed a sophisticated mathematical model to better…
#Environment #Antibody #Antibody-DrugConjugate #blood #cancer #CancerTherapy #efficacy #Immunomodulatory #immunotherapy #oncology #research #therapy #Tumor #Vascular
https://www.europesays.com/3281120/ -
https://www.europesays.com/ie/712273/ New study explains how TMEM63B protein regulates cell membranes #Antibody #Cell #Éire #IE #Intracellular #Ireland #Lipids #Membrane #NeurodegenerativeDisease #Protein #Research #Science
-
AstraZeneca scales Summit’s PD-1xVEGF strategy with $2B investment to fuel ADC combos
AstraZeneca is investing $2 billion in Summit Therapeutics to accelerate the development of PD-1xVEGF bispecific ivonescimab in combination with…
#EuropeSays #Britain #Europe #EU #AstraZeneca #antibody-drugconjugates #biotech #Deals #drugcombinations #FierceBiotechHomepage #FiercePharmaHomepage #PD-1 #SummitTherapeutics #VEGF
https://www.europesays.com/britain/133635/ -
This Startup Is Using #AI to Fight Off a Future AI #Pandemic
#RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b
https://archive.is/20260928010231/https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b -
This Startup Is Using #AI to Fight Off a Future AI #Pandemic
#RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b
https://archive.is/20260928010231/https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b -
This Startup Is Using #AI to Fight Off a Future AI #Pandemic
#RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b
https://archive.is/20260928010231/https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b -
This Startup Is Using #AI to Fight Off a Future AI #Pandemic
#RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b
https://archive.is/20260928010231/https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b -
This Startup Is Using #AI to Fight Off a Future AI #Pandemic
#RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b
https://archive.is/20260928010231/https://www.wsj.com/health/this-startup-is-using-ai-to-fight-off-a-future-ai-pandemic-aceedf1b